The 30 references in paper M. Zafranskaya M., D. Nizhegorodova B., M. Yurkevich Yu., S. Bagatka S., H. Ivanchyk I., Yana Motuzova M., A. Fedulov S., М. Зафранская М., Д. Нижегородова Б., М. Юркевич Ю., С. Багатка С., Г. Иванчик И., Я. Мотузова М., А. Федулов С. (2014) “МЕХАНИЗМЫ АНТИПРОЛИФЕРАТИВНОГО ДЕЙСТВИЯ МЕЗЕНХИМАЛЬНЫХ СТВОЛОВЫХ КЛЕТОК У ПАЦИЕНТОВ С РАССЕЯННЫМ СКЛЕРОЗОМ // MECHANISMS OF ANTI-PROLIFERATIVE EFFECT PRODUCED BY MESENCHYMAL STEM CELLS IN PATIENTS WITH MULTIPLE SCLEROSIS” / spz:neicon:mimmun:y:2011:i:3:p:237-246

1
Зафранская М.М., Федулов А.С., Нижегородова Д.Б., Мотузова Я.М., Юркевич М.Ю., Багатка С.С., Миланович Н.Ф. Влияние мезенхимальных стволовых клеток на пролиферацию Т-клеток памяти у пациентов с рассеянным склерозом // Вести Нац. Акад. Наук Беларуси. –
(check this in PDF content)
2
10. – No 3. – C. 24-31. 2. Нижегородова Д.Б., Эберль М., Зафранская М.М. Современные аспекты иммунопатогенеза рассеянного склероза // Иммунопатология, аллергология, инфектология. – 2005. – No 2. – С. 44-55.
(check this in PDF content)
3
Bai L., Lennon D., Eaton V., Maier K., Caplan A., Miller S., Miller R. Human bone marrowderived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis // Glia. – 2009. – Vol. 57, N 11. – P. 1192-1203.
(check this in PDF content)
4
Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Lonqoni P., Matteucci P., Grisanti S., Gianni A. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli // Blood. – 2002. – Vol. 99. – P. 3838-3843.
(check this in PDF content)
5
English R., Ryan J., Tobin L., Murphy M., Barry F., Mahon B. Cell contact, PGE2 and TGF beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25HighFOXP3+ regulatory T cеlls // Clinical and Experimental Immunology. – 2009. – Vol.156. – P. 149-160.
(check this in PDF content)
6
Gerdoni E., Gallo B., Casazza S., Musio S., Bonanni I., Pedemonte E., Manteqazza R., Frassoni F., Mancardi G., Pedotti R., Uccelli A. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis // Ann. Neurol. – 2007. – Vol. 61, N 3. – P. 219-227.
(check this in PDF content)
7
Glenie S., Soeiro I., Dyson P., Lam E., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005; 105:2821-2827.
(check this in PDF content)
8
Hafler D. Multiple sclerosis // The journal of clinical investigation. – 2004. – Vol. 113, N 6. – Р. 788-794.
(check this in PDF content)
9
Holmoy T. Immunopathogenesis of multiple sclerosis: concepts and controversies // Acta Neurol. Scand. – 2007. – N 115. – Р. 39-45.
(check this in PDF content)
10
Hwu P., Du M., Lapointe R., Do M., Taylor M., Young H. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T-cell proliferation // J. Immunol. – 2000. – Vol. 164, N 7. – P. 3596-3599.
(check this in PDF content)
11
Karussis D., Kassis I., Kurkalli B., Slavin S. Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological/neurodegenerative diseases // J. Neurol. Sci. – 2008. – Vol. 265, N 1-2. – Р. 131135.
(check this in PDF content)
12
Koehler N., Genain C., Giesser B., Hauser S. The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study // J. Immunol. – 2002. – No 168. – Р. 59205927.
(check this in PDF content)
13
Krampera M., Franchini M., Pizzolo G., Aprili G. Mesenchymal stem cells: from biology to clinical use // Blood Transfus. – 2007. – Vol. 5. – P. 120-129.
(check this in PDF content)
14
Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation // Blood. – 2004. – Vol. 103, N 12. – Р. 4619-4621.
(check this in PDF content)
15
Mellor A. Indoleamine 2,3 dioxygenase and regulation of T cell immunity // Biochem. Biophys. Res. Commun. – 2005. – Vol. 338. – P. 20-24.
(check this in PDF content)
16
Muller A., Prendergast G.C. Indoleamine 2,3-dioxygenase in immune suppression and cancer // Current Cancer Drug Targets. – 2007. – Vol. 7. – P. 31-40.
(check this in PDF content)
17
Nauta А., Fibbe W. Immunomodulatory properties of mesenchymal stromal cells // Blood. – 2007. – Vol. 110. – P. 3499-3506.
(check this in PDF content)
18
Pender M., Wolfe N. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects // Intern. Med. J. – 2002. – Vol. 32, N 11. – Р. 554-563.
(check this in PDF content)
19
Prevosto C., Zancolli M., Canevali P., Zocchi M., Poggi A. Generation of CD4+/CD8+ regulatory T cells upon mesenchymal stem celllymphocyte interaction // Нaematologica. – 2007. – Vol. 92. – Р. 321-326.
(check this in PDF content)
20
Rasmusson I., Ringden O., Sundberg B., Le Blank K. Mesenchymal stem cell inhibit lymphocytes proliferation by mitogens and alloantigens by different mechanisms // Exp. Cell. Res. – 2005. – Vol. 305. – Р. 33-41.
(check this in PDF content)
21
Ryan J., Barry F., Murphy J., Mahon B. Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells // Clin. Exp. Immunol. – 2007. – Vol. 149. – P. 353-363.
(check this in PDF content)
22
Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., Xu C., Chen X., Huang Y., Zhu Z., Huang X., Han X., Xie N., Ren G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair // Cell Research. – 2010. – Vol. 20. – P. 510-518.
(check this in PDF content)
23
Sospedra M., Martin R. Immunology of multiple sclerosis // Annual review immunology. – 2005. – N 23. – Р. 683-747.
(check this in PDF content)
24
Steinman L. Immunotherapy of multiple sclerosis: the end of the beginning // Curr. Opin. Immunol. – 2001. – Vol. 13, N 5. – Р. 597-600.
(check this in PDF content)
25
Tilley S., Coffman T., Koller B. Mixed message: modulation of inflamation and immune responses by prostaglandins and thromboxane // J. Clin. Invest. – 2001. – Vol. 108. – P. 15-19.
(check this in PDF content)
26
Tyndall A., Uccelli A. Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks // Bone Marrow Transplant. – 2009. – Vol. 43, N 11. – Р. 821-828.
(check this in PDF content)
27
Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease // Nat. Rev. Immunol. – 2008. – Vol. 8, N 9. – P. 726-736.
(check this in PDF content)
28
Zafranskaya M., Oschmann P., Engel R., Weishaupt A., van Noort J., Jomaa H., Eberl M. Interferon-β therapy reduce CD4+ and CD8+ T-cell reactivity in multiple sclerosis // Immunology. – 2007. – Vol. 121, N 1. – P. 29-39.
(check this in PDF content)
29
Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., Giunti D., Ceravolo A., Cazzanti F., Frassoni F., Mancardi G., Uccelli A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy // Blood. – 2005. – Vol. 106, N 5. – P. 1755-1761.
(check this in PDF content)
30
Zhang J., Li Y., Chen J., Cui Y., Lu M., Elias S., Mitchell J. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice // Exp. Neurol. – 2005. – Vol. 195. – P. 16-26.
(check this in PDF content)